Ganoderic acid A

CAS No. 81907-62-2

Ganoderic acid A( —— )

Catalog No. M19142 CAS No. 81907-62-2

Ganoderic acid A exhibits antitumor activity, mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 106 In Stock
5MG 93 In Stock
10MG 155 In Stock
25MG 250 In Stock
50MG 365 In Stock
100MG 536 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ganoderic acid A
  • Note
    Research use only, not for human use.
  • Brief Description
    Ganoderic acid A exhibits antitumor activity, mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1.
  • Description
    Ganoderic acids are a class of closely related triterpenoids (derivatives from lanosterol) found in Ganoderma mushrooms. For thousands of years, the fruiting bodies of Ganoderma fungi have been used in traditional medicines in East Asia. Consequently, there have been efforts to identify the chemical constituents that may be responsible for the putative pharmacological effects. There are dozens of ganoderic acids that have been isolated and characterized, of which ganoderic acid A and ganoderic acid B are the most well characterized. Some ganoderic acids have been found to possess biological activities including hepatoprotection, anti-tumor effects, and 5-alpha reductase inhibition.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    NF-κB
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    81907-62-2
  • Formula Weight
    516.67
  • Molecular Formula
    C30H44O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 29 mg/mL; 56.13 mM
  • SMILES
    CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O
  • Chemical Name
    (25R)-7β,15α-Dihydroxy-3,11,23-trioxo-5α-lanost-8-en-26-oic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Secukinumab B

    Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.

  • Guselkumab

    Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit.

  • Umbelliprenin

    Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.